Literature DB >> 18854659

Overexpression of thymosin beta-10 inhibits VEGF mRNA expression, autocrine VEGF protein production, and tube formation in hypoxia-induced monkey choroid-retinal endothelial cells.

Tonghe Zhang1, Xiaoxin Li, Wenzhen Yu, Zheng Yan, He Zou, Xiangjun He.   

Abstract

PURPOSE: One purpose of this study was to examine if expression of the thymosin beta(10 )(TB10), thymosin beta(4) (TB4), and VEGF165 isoform genes would change in response to hypoxia in monkey choroidal retinal endothelial cells (RF/6A). We also sought to determine if overexpression of the TB10 gene could inhibit VEGF165 mRNA expression, autocrine VEGF production, and tube formation in hypoxic RF/6A cells.
METHODS: An adenovirus vector, Ad-TB10, was constructed to deliver the human TB10 gene. Under hypoxic conditions, TB10, TB4, and VEGF165 mRNA were measured using real-time PCR, and VEGF protein expression was evaluated by ELISA. For tube formation assays, the RF/6A cells were transfected with Ad-TB10 and exposed to hypoxia for 4 h.
RESULTS: VEGF165 mRNA was 2- and 5.8-fold increased when the RF/6A cells were exposed to hypoxia for 2 and 4 h, respectively. TB10 mRNA decreased at 2 h and increased to a baseline level at 4 h, while TB4 mRNA level increased slightly by 2 and 4 h. Increased VEGF165 mRNA was down-regulated by transfected Ad-TB10, and ELISA results showed that VEGF protein levels increased 2.4-fold after 4-hour hypoxia, and decreased 2-fold after transfection with Ad-TB10. Hypoxia also induced tube formation of the RF/6A cells. This was significantly reduced by Ad-TB10.
CONCLUSION: These data indicate that (1) TB4 and TB10 mRNA expression in RF/6A cells present different changes under 2- and 4-hour hypoxia, and (2) TB10 may be an effective inhibitor of angiogenesis by inhibiting VEGF expression and autocrine protein production. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854659     DOI: 10.1159/000163220

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  8 in total

1.  Recombinant Expression and Bioactivity Characterization of TAT-Fused Thymosin β10.

Authors:  Kunzhi Jia; Ming Lin; Defeng Kong; Qi Jia
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

2.  Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator.

Authors:  Eun-Yi Moon; Yun-Sun Im; Yun-Kyoung Ryu; Joo-Hyun Kang
Journal:  Clin Exp Metastasis       Date:  2010-09-07       Impact factor: 5.150

3.  Revealing new mouse epicardial cell markers through transcriptomics.

Authors:  Lars Bochmann; Padmini Sarathchandra; Federica Mori; Enrique Lara-Pezzi; Domenico Lazzaro; Nadia Rosenthal
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

4.  β-Thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up.

Authors:  Maria De Santis; Rosanna Inzitari; Silvia L Bosello; Giusy Peluso; Chiara Fanali; Federica Iavarone; Gaetano Zizzo; Mario Bocci; Tiziana Cabras; Irene Messana; Leo Fuso; Francesco Varone; Gabriella Pagliari; Massimo Castagnola; Gianfranco Ferraccioli
Journal:  Respir Res       Date:  2011-02-11

5.  Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration.

Authors:  Wei Zhang; Wenhui Chu; Qingxiu Liu; Dawn Coates; Yudong Shang; Chunyi Li
Journal:  Stem Cell Res Ther       Date:  2018-06-19       Impact factor: 6.832

6.  Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells.

Authors:  Lvzhen Huang; Wenzhen Yu; Xiaoxin Li; Yongsheng Xu; Lanjun Niu; Xiangjun He; Jianqiang Dong; Zheng Yan
Journal:  Mol Vis       Date:  2009-05-29       Impact factor: 2.367

7.  Genetic and functional dissection of ARMS2 in age-related macular degeneration and polypoidal choroidal vasculopathy.

Authors:  Yong Cheng; LvZhen Huang; Xiaoxin Li; Peng Zhou; Wotan Zeng; ChunFang Zhang
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

8.  IGFBP‑rP1‑silencing promotes hypoxia‑induced angiogenic potential of choroidal endothelial cells via the RAF/MEK/ERK signaling pathway.

Authors:  Shuting Zhu; Hong Wang; Zhihua Zhang; Mingming Ma; Zhi Zheng; Xun Xu; Tao Sun
Journal:  Mol Med Rep       Date:  2020-10-11       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.